News Bill Gates enters dementia research with $50m donation Fund is challenging prevailing 'amyloid hypothesis'
News Reimbursement remains biggest barrier to precision drugs Reimbursement more of a barrier than regulation
News Novartis and Amgen search for Alzheimer's prevention drug Novartis and Amgen have expanded an existing collaboration with Arizona’s Banner Alzheimer’s Institute (BAI), and begun a major study investigating whether a BACE1 inhibitor drug can delay
News Surge of Alzheimer's drugs in pipeline gives hope of progres... Authors "optimistic" despite issues with front runners from AB Science and Otsuka
News Merck tries again in Alzheimer's with Teijin's tau antibody Target is implicated in a number of nervous system diseases.
News Biogen shares up after strong launch for rare disease drug US insurers are covering the treatment, despite high price.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
